Mark Asset Management Corp Sells 12,324 Shares of CME Group Inc (CME)

Mark Asset Management Corp decreased its holdings in CME Group Inc (NASDAQ:CME) by 16.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 62,714 shares of the financial services provider’s stock after selling 12,324 shares during the period. CME Group accounts for about 2.5% of Mark Asset Management Corp’s holdings, making the stock its 16th biggest position. Mark Asset Management Corp’s holdings in CME Group were worth $10,675,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. BlackRock Inc. lifted its position in CME Group by 1.8% during the third quarter. BlackRock Inc. now owns 22,422,112 shares of the financial services provider’s stock valued at $3,816,468,000 after purchasing an additional 403,327 shares during the last quarter. Edgewood Management LLC lifted its position in CME Group by 9.5% during the third quarter. Edgewood Management LLC now owns 8,582,518 shares of the financial services provider’s stock valued at $1,460,830,000 after purchasing an additional 742,067 shares during the last quarter. Janus Henderson Group PLC lifted its position in CME Group by 3.3% during the third quarter. Janus Henderson Group PLC now owns 6,331,522 shares of the financial services provider’s stock valued at $1,077,689,000 after purchasing an additional 202,365 shares during the last quarter. Thornburg Investment Management Inc. lifted its position in CME Group by 3.8% during the third quarter. Thornburg Investment Management Inc. now owns 3,614,874 shares of the financial services provider’s stock valued at $615,288,000 after purchasing an additional 132,991 shares during the last quarter. Finally, FMR LLC lifted its position in CME Group by 5.4% during the third quarter. FMR LLC now owns 2,887,099 shares of the financial services provider’s stock valued at $491,413,000 after purchasing an additional 147,301 shares during the last quarter. Hedge funds and other institutional investors own 85.89% of the company’s stock.

In other news, CFO John W. Pietrowicz sold 2,500 shares of the business’s stock in a transaction on Thursday, October 11th. The shares were sold at an average price of $179.86, for a total transaction of $449,650.00. Following the sale, the chief financial officer now owns 32,720 shares in the company, valued at approximately $5,885,019.20. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Chairman Terrence A. Duffy sold 10,000 shares of the business’s stock in a transaction on Friday, November 23rd. The shares were sold at an average price of $188.80, for a total transaction of $1,888,000.00. Following the sale, the chairman now owns 95,652 shares in the company, valued at approximately $18,059,097.60. The disclosure for this sale can be found here. Over the last three months, insiders have sold 29,800 shares of company stock worth $5,628,462. Insiders own 0.43% of the company’s stock.

Several research analysts have commented on CME shares. Zacks Investment Research downgraded shares of CME Group from a “hold” rating to a “sell” rating in a research note on Wednesday, August 22nd. Berenberg Bank raised shares of CME Group from a “hold” rating to a “buy” rating and set a $220.00 target price on the stock in a research note on Tuesday, November 20th. UBS Group downgraded shares of CME Group from a “buy” rating to a “neutral” rating and lifted their target price for the stock from $185.00 to $204.00 in a research note on Wednesday, November 28th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $190.00 target price on shares of CME Group in a research note on Wednesday, September 5th. Finally, Barclays began coverage on shares of CME Group in a research note on Tuesday. They issued an “overweight” rating and a $210.00 target price on the stock. Six analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company. CME Group presently has a consensus rating of “Buy” and a consensus target price of $194.13.

Shares of CME Group stock opened at $188.20 on Wednesday. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.15. The firm has a market cap of $64.60 billion, a price-to-earnings ratio of 39.45, a P/E/G ratio of 2.19 and a beta of 0.46. CME Group Inc has a 12-month low of $143.68 and a 12-month high of $197.08.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Thursday, October 25th. The financial services provider reported $1.45 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.42 by $0.03. The business had revenue of $904.20 million for the quarter, compared to the consensus estimate of $910.50 million. CME Group had a net margin of 113.67% and a return on equity of 9.18%. On average, analysts forecast that CME Group Inc will post 6.65 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 27th. Shareholders of record on Monday, December 10th will be given a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a yield of 1.49%. The ex-dividend date is Friday, December 7th. CME Group’s payout ratio is currently 58.70%.

ILLEGAL ACTIVITY WARNING: “Mark Asset Management Corp Sells 12,324 Shares of CME Group Inc (CME)” was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece on another domain, it was illegally stolen and republished in violation of US and international copyright legislation. The original version of this piece can be accessed at https://www.dispatchtribunal.com/2018/12/05/mark-asset-management-corp-sells-12324-shares-of-cme-group-inc-cme.html.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Featured Article: What is the yield curve?

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply